RARRES2 and obesity due to melanocortin 4 receptor deficiency: Elevated plasma chemerin levels have been observed in patients with obesity, type 2 diabetes, and cardiovascular diseases, and these levels often decrease following weight-loss interventions like bariatric surgery or calorie restriction [31].